Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

0A4J

Astrazeneca (0A4J)

Astrazeneca Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0A4J
일자시간출처헤드라인심볼기업
2024/01/0300:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/12/2716:00UK RegulatoryAstraZeneca PLC AstraZeneca acquires GracellLSE:0A4JAstrazeneca Plc
2023/12/2216:00UK RegulatoryAstraZeneca PLC Wainua (eplontersen) granted first US FDA approvalLSE:0A4JAstrazeneca Plc
2023/12/1500:00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
2023/12/1216:05UK RegulatoryAstraZeneca PLC AstraZeneca to acquire IcosavaxLSE:0A4JAstrazeneca Plc
2023/12/0200:05UK RegulatoryAstraZeneca PLC Block listing Interim ReviewLSE:0A4JAstrazeneca Plc
2023/12/0200:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/12/0116:00UK RegulatoryAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trialsLSE:0A4JAstrazeneca Plc
2023/11/2400:00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
2023/11/1716:00UK RegulatoryAstraZeneca PLC Truqap approved in US for HR+ breast cancerLSE:0A4JAstrazeneca Plc
2023/11/1416:05UK RegulatoryAstraZeneca PLC Update on PACIFIC-2 Phase III trial for ImfinziLSE:0A4JAstrazeneca Plc
2023/11/1000:00UK RegulatoryAstraZeneca PLC Director DeclarationLSE:0A4JAstrazeneca Plc
2023/11/0916:10UK RegulatoryAstraZeneca PLC Imfinzi combination improves PFS in liver cancerLSE:0A4JAstrazeneca Plc
2023/11/0916:05UK RegulatoryAstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RALSE:0A4JAstrazeneca Plc
2023/11/0916:00UK RegulatoryAstraZeneca PLC 9M and Q3 2023 resultsLSE:0A4JAstrazeneca Plc
2023/11/0200:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/11/0116:00UK RegulatoryAstraZeneca PLC AstraZeneca cell & gene therapy deal w/ CellectisLSE:0A4JAstrazeneca Plc
2023/10/0315:00UK RegulatoryAstraZeneca PLC AstraZeneca settles Nexium liability litigationsLSE:0A4JAstrazeneca Plc
2023/10/0223:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/09/2215:00UK RegulatoryAstraZeneca PLC Dato-DXd improved PFS in breast cancerLSE:0A4JAstrazeneca Plc
2023/09/2015:00UK RegulatoryAstraZeneca PLC Alexion completes Pfizer gene therapy agreementLSE:0A4JAstrazeneca Plc
2023/09/1523:00UK RegulatoryAstraZeneca PLC Enhertu recommended in EU for HER2-mutant NSCLCLSE:0A4JAstrazeneca Plc
2023/09/1200:00UK RegulatoryAstraZeneca PLC Fasenra Phase III EGPA trial met primary endpointLSE:0A4JAstrazeneca Plc
2023/09/0615:00UK RegulatoryAstraZeneca PLC Update on US review of Ultomiris for NMOSDLSE:0A4JAstrazeneca Plc
2023/09/0123:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/08/0123:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/07/2815:05UK RegulatoryAstraZeneca PLC Alexion enters gene therapy agreement with PfizerLSE:0A4JAstrazeneca Plc
2023/07/2815:00UK RegulatoryAstraZeneca PLC Half-year ReportLSE:0A4JAstrazeneca Plc
2023/07/1802:10UK RegulatoryAstraZeneca PLC Beyfortus approved in US for infant RSV preventionLSE:0A4JAstrazeneca Plc
2023/07/0323:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
 검색 관련기사 보기:LSE:0A4J